Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo

Cell Transplantation

Volumn 21, Issue 4, 2012, Pages 723-737

  Boltze, Johannes ^a,b   Reich, Doreen M ^a   Hau, Susann ^a,c   Reymann, Klaus G ^d   Strassburger, Maria ^d   Lobsien, Donald ^b   Wagner, Daniel Christoph ^a   Kamprad, Manja ^b   Stahl, Tobias ^b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c VITA34 AG   (Germany)

^d LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

Cell therapy; Cell transplantation; Human umbilical cord blood (hUCB); Magnetic resonance imaging; Neuroprotection; Stroke

Indexed keywords

CD34 ANTIGEN; GLUCOSE; OXYGEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; BRAIN TISSUE; CELL COUNT; CELL LINE; CELL MIGRATION; CELL PROTECTION; CELL SUBPOPULATION; CELL THERAPY; COCULTURE; FLOW CYTOMETRY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; UMBILICAL CORD BLOOD;

RATTUS; RODENTIA;

ANIMALS; ANTIGENS, CD34; CELLS, CULTURED; FETAL BLOOD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE GROWTH FACTORS; RATS; RATS, INBRED SHR; STROKE;

EID: 84930483851     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911x586783     Document Type: Article

References (46)

1. Aiuti, A.; Webb, I. J.; Bleul, C.; Springer, T.; Gutierrez- Ramos, J. C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185: 111-120; 1997.
2. Arien-Zakay, H.; Lecht, S.; Bercu, M. M.; Tabakman, R.; Kohen, R.; Galski, H.; Nagler, A.; Lazarovici, P. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp. Neurol. 216:83-94; 2009.
3. Back, T.; Schuler, O. G. The natural course of lesion development in brain ischemia. Acta Neurochir. Suppl. 89:55-61; 2004.
4. Bleul, C. C.; Fuhlbrigge, R. C.; Casasnovas, J. M.; Aiuti, A.; Springer, T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101-1109; 1996.
5. Borlongan, C. V.; Hadman, M.; Sanberg, C. D.; Sanberg, P. R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35:2385-2389; 2004.
6. Bracci-Laudiero, L.; Celestino, D.; Starace, G.; Antonelli, A.; Lambiase, A.; Procoli, A.; Rumi, C.; Lai, M.; Picardi, A.; Ballatore, G.; Bonini, S.; Aloe, L. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J. Neuroimmunol. 136: 130-139; 2003.
7. Brown, J. A.; Boussiotis, V. A. Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution. Clin. Immunol. 127:286-297; 2008.
8. Chen, J.; Sanberg, P. R.; Li, Y.; Wang, L.; Lu, M.; Willing, A. E.; Sanchez-Ramos, J.; Chopp, M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-2688; 2001.
9. Dasari, V. R.; Veeravalli, K. K.; Saving, K. L.; Gujrati, M.; Fassett, D.; Klopfenstein, J. D.; Dinh, D. H.; Rao, J. S. Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway. Neurobiol. Dis. 32:486-498; 2008.
10. Endres, M.; Dirnagl, U. Ischemia and stroke. Adv. Exp. Med. Biol. 513:455-473; 2002.
11. Feng, G.; Mellor, R. H.; Bernstein, M.; Keller-Peck, C.; Nguyen, Q. T.; Wallace, M.; Nerbonne, J. M.; Lichtman, J. W.; Sanes, J. R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51; 2000.
12. Greschat, S.; Schira, J.; Kury, P.; Rosenbaum, C.; de Souza Silva, M. A.; Kogler, G.; Wernet, P.; Muller, H. W. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev. 17:221-232; 2008.
13. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Davalos, A.; Guidetti, D.; Larrue, V.; Lees, K. R.; Medeghri, Z.; Machnig, T.; Schneider, D.; von Kummer, R.; Wahlgren, N.; Toni, D.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359:1317-1329; 2008.
14. Hall, A. A.; Guyer, A. G.; Leonardo, C. C.; Ajmo, Jr., C. T.; Collier, L. A.; Willing, A. E.; Pennypacker, K. R. Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death. J. Neurosci. Res. 87:333-341; 2009.
15. Hau, S.; Reich, D. M.; Scholz, M.; Naumann, W.; Emmrich, F.; Kamprad, M.; Boltze, J. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci. 9:30; 2008.
16. Hayashi, K.; Ishizuka, S.; Yokoyama, C.; Hatae, T. Attenuation of interferon-gamma mRNA expression in activated Jurkat T cells by exogenous zinc via down-regulation of the calcium-independent PKC-AP-1 signaling pathway. Life Sci. 83:6-11; 2008.
17. Himeda, T.; Tounai, H.; Hayakawa, N.; Araki, T. Postis- chemic alterations of BDNF, NGF, HSP 70 and ubiquitin immunoreactivity in the gerbil hippocampus: Pharmacological approach. Cell. Mol. Neurobiol. 27:229-250; 2007.
18. Jiang, L.; Womble, T.; Saporta, S.; Chen, N.; Sanberg, C. D.; Sanberg, P. R.; Willing, A. E. Human umbilical cord blood cells decrease microglial survival in vitro. Stem Cells Dev. 19:221-228; 2010.
19. Leonardo, C. C.; Hall, A. A.; Collier, L. A.; Ajmo, Jr., C. T.; Willing, A. E.; Pennypacker, K. R. Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J. Neurosci. Res. 88:1213-1222; 2010.
20. Newcomb, J. D.; Ajmo, Jr., C. T.; Sanberg, C. D.; Sanberg, P. R.; Pennypacker, K. R.; Willing, A. E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15:213-223; 2006.
21. Newman, M. B.; Willing, A. E.; Manresa, J. J.; Sanberg, C. D.; Sanberg, P. R. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: Implications for brain repair. Exp. Neurol. 199:201-208; 2006.
22. Newman, M. B.; Willing, A. E.; Manresa, J. J.; Davis- Sanberg, C.; Sanberg, P. R. Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev. 14:576-586; 2005.
23. Ou, Y.; Yu, S.; Kaneko, Y.; Tajiri, N.; Bae, E. C.; Chheda, S. H.; Stahl, C. E.; Yang, T.; Fang, L.; Hu, K.; Borlongan, C. V.; Yu, G. Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Res. 1366:217-225; 2010.
24. Park, D. H.; Borlongan, C. V.; Willing, A. E.; Eve, D. J.; Cruz, L. E.; Sanberg, C. D.; Chung, Y. G.; Sanberg, P. R. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 18:985-998; 2009.
25. Piao, C. S.; Gonzalez-Toledo, M. E.; Xue, Y. Q.; Duan, W. M.; Terao, S.; Granger, D. N.; Kelley, R. E.; Zhao, L. R. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke. J. Cereb. Blood Flow Metab. 29:759-770; 2009.
26. Rainsford, E.; Reen, D. J. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br. J. Haematol. 116:702-709; 2002.
27. Reich, D. M.; Hau, S.; Stahl, T.; Scholz, M.; Naumann, W.; Emmrich, F.; Boltze, J.; Kamprad, M. Neuronal hypoxia in vitro: Investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells. BMC Neurosci. 9: 91; 2008.
28. Sanberg, P. R.; Park, D. H.; Kuzmin-Nichols, N.; Cruz, E.; Hossne, Jr., N. A.; Buffolo, E.; Willing, A. E. Monocyte transplantation for neural and cardiovascular ischemia repair. J. Cell. Mol. Med. 14:553-563; 2010.
29. Sanberg, P. R.; Willing, A. E.; Garbuzova-Davis, S.; Saporta, S.; Liu, G.; Sanberg, C. D.; Bickford, P. C.; Klasko, S. K.; El-Badri, N. S. Umbilical cord blood- derived stem cells and brain repair. Ann. NY Acad. Sci. 1049:67-83; 2005.
30. Sarnowska, A.; Braun, H.; Sauerzweig, S.; Reymann, K. G. The neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue. Exp. Neurol. 215:317-327; 2009.
31. Schmid-Brunclik, N.; Burgi-Taboada, C.; Antoniou, X.; Gassmann, M.; Ogunshola, O. O. Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295:R864-R873; 2008.
32. Shichita, T.; Sugiyama, Y.; Ooboshi, H.; Sugimori, H.; Nakagawa, R.; Takada, I.; Iwaki, T.; Okada, Y.; Iida, M.; Cua, D. J.; Iwakura, Y.; Yoshimura, A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15: 946-950; 2009.
33. Shigeno, T.; Mima, T.; Takakura, K.; Graham, D. I.; Kato, G.; Hashimoto, Y.; Furukawa, S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:2914-2919; 1991.
34. Stoppini, L.; Buchs, P. A.; Muller, D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37:173-182; 1991.
35. Stroh, A.; Boltze, J.; Sieland, K.; Hild, K.; Gutzeit, C.; Jung, T.; Kressel, J.; Hau, S.; Reich, D.; Grune, T.; Zimmer, C. Impact of magnetic labeling on human and mouse stem cells and their long-term magnetic resonance tracking in a rat model of Parkinson disease. Mol. Imaging. 8:166-178; 2009.
36. Sutherland, D. R.; Anderson, L.; Keeney, M.; Nayar, R.; Chin-Yee, I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J. Hematother. 5: 213-226; 1996.
37. Taguchi, A.; Soma, T.; Tanaka, H.; Kanda, T.; Nishimura, H.; Yoshikawa, H.; Tsukamoto, Y.; Iso, H.; Fujimori, Y.; Stern, D. M.; Naritomi, H.; Matsuyama, T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114:330-338; 2004.
38. Traystman, R. J. Animal models of focal and global cerebral ischemia. ILAR J. 44:85-95; 2003.
39. Vanneaux, V.; El-Ayoubi, F.; Delmau, C.; Driancourt, C.; Lecourt, S.; Grelier, A.; Cras, A.; Cuccuini, W.; Soulier, J.; Lataillade, J. J.; Lebousse-Kerdiles, M. C.; Oury, J. F.; Sibony, O.; Marolleau, J. P.; Benbunan, M.; Uzan, G.; Larghero, J. In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: Are we ready for clinical application? Cell Transplant. 19(9):1143-1155; 2010.
40. Vendrame, M.; Cassady, J.; Newcomb, J.; Butler, T.; Pennypacker, K. R.; Zigova, T.; Sanberg, C. D.; Sanberg, P. R.; Willing, A. E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390-2395; 2004.
41. Vendrame, M.; Gemma, C.; de Mesquita, D.; Collier, L.; Bickford, P. C.; Sanberg, C. D.; Sanberg, P. R.; Pennypacker, K. R.; Willing, A. E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14:595-604; 2005.
42. Vendrame, M.; Gemma, C.; Pennypacker, K. R.; Bickford, P. C.; Davis, S. C.; Sanberg, P. R.; Willing, A. E. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 199:191-200; 2006.
43. Xu, X. H.; Zhang, S. M.; Yan, W. M.; Li, X. R.; Zhang, H. Y.; Zheng, X. X. Development of cerebral infarction, apoptotic cell death and expression of X-chromosome- linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 78:704-712; 2006.
44. Yamashita, T.; Deguchi, K.; Nagotani, S.; Kamiya, T.; Abe, K. Gene and stem cell therapy in ischemic stroke. Cell Transplant. 18:999-1002; 2009.
45. Yu, G.; Borlongan, C. V.; Stahl, C. E.; Hess, D. C.; Ou, Y.; Kaneko, Y.; Yu, S. J.; Yang, T.; Fang, L.; Xie, X. Systemic delivery of umbilical cord blood cells for stroke therapy: A review. Restor. Neurol. Neurosci. 27:41-54; 2009.
46. Zigova, T.; Song, S.; Willing, A. E.; Hudson, J. E.; Newman, M. B.; Saporta, S.; Sanchez-Ramos, J.; Sanberg, P. R. Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant. 11:265-274; 2002.